Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

279 Press Releases
DateTitleCompany
26 Aug 16 Takeda Announces Bold, New Access to Medicines Strategy Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Aug 16 Takeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Aug 16 Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
29 Jul 16 Takeda Reports 1st Quarter 2016 Results with a Strong Start to the Year and Confidence in Management Guidance Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Jul 16 Takeda and the Crohn's & Colitis Foundation of America Partner to Introduce 'IBD Unmasked' A First-of-its-Kind Awareness Campaign Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
13 Jul 16 IBD Unmasked, a First-of-its-Kind Global Awareness Initiative, Launches to Support and Empower the Inflammatory Bowel Disease Community Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
05 Jul 16 Takeda Submits a New Drug Application for Novel, Oral Proteasome Inhibitor Ixazomib in Japan Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Jul 16 Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
01 Jul 16 Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis Takeda Pharmaceutical Company Limited,
Published by
Business Wire
22 Jun 16 TB Alliance and Takeda Announce Advancement of Joint Program Investigating Promising Compounds for Novel TB Therapies Through Global Health Innovative Technology Fund Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Jun 16 Takeda Initiates World’s First Norovirus Vaccine Field Trial Takeda Pharmaceutical Company Limited,
Published by
Business Wire
17 Jun 16 Takeda and M2Gen Collaborate with ORIEN to Speed Clinical Development and Discovery of Cancer Treatments Through Health Informatics Takeda ,
Published by
PharmiWeb.com
16 Jun 16 Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership with Takeda Pharmaceutical Company, Ltd. Takeda Pharmaceutical Company, Ltd.,
Published by
Business Wire
15 Jun 16 EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care Takeda Pharmaceutical Company Limited
01 Jun 16 Trintellix (vortioxetine) Now Available in U.S. Pharmacies Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
27 May 16 Takeda Provides Update on EU Marketing Authorization Application for NINLARO® (ixazomib) in Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
27 May 16 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
16 May 16 Takeda and Lundbeck Present Vortioxetine Data at the American Psychiatric Association (APA) 2016 Annual Meeting Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
05 Feb 16 Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year Takeda ,
Published by
PharmiWeb.com
15 Mar 16 Takeda and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Apr 16 Takeda Launches Multi-Year Research Partnership with Leading Inflammatory Bowel Disease Institutions Takeda ,
Published by
PharmiWeb.com
03 Feb 16 Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and XMT-1522 Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Feb 16 FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD) Takeda Pharmaceutical ,
Published by
PharmiWeb.com
12 May 16 Takeda Appoints New Chief Financial Officer, James Kehoe Takeda Pharmaceutical Company Limited,
Published by
Business Wire
29 Apr 16 Phase 3 Trial Results for the Oral Proteasome Inhibitor Ixazomib Published in The New England Journal of Medicine Takeda UK
27 Apr 16 Phase 3 Trial Results for First Oral Proteasome Inhibitor NINLARO (ixazomib) Published in The New England Journal of Medicine Takeda Pharmaceutical Company Limited,
Published by
Business Wire
30 Mar 16 Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA Takeda ,
Published by
PharmiWeb.com
29 Jan 16 Boehringer Ingelheim's Gilotrif® (afatinib) demonstrated superiority to Iressa® (gefitinib) in reducing the risk of disease progression and treatment failure in first-line treatment of patients with EGFR mutation-positive advanced non-small cell lung cancer Takeda Pharmaceuticals,
Published by
PharmiWeb.com
09 May 16 Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries Takeda Pharmaceutical Company Limited,
Published by
Business Wire
03 Feb 16 Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year Takeda Pharmaceutical Company Limited,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.